Peter W. Krenn

828 total citations
18 papers, 472 citations indexed

About

Peter W. Krenn is a scholar working on Molecular Biology, Immunology and Hematology. According to data from OpenAlex, Peter W. Krenn has authored 18 papers receiving a total of 472 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Immunology and 6 papers in Hematology. Recurrent topics in Peter W. Krenn's work include Chronic Lymphocytic Leukemia Research (4 papers), Acute Myeloid Leukemia Research (3 papers) and Platelet Disorders and Treatments (3 papers). Peter W. Krenn is often cited by papers focused on Chronic Lymphocytic Leukemia Research (4 papers), Acute Myeloid Leukemia Research (3 papers) and Platelet Disorders and Treatments (3 papers). Peter W. Krenn collaborates with scholars based in Austria, Germany and Italy. Peter W. Krenn's co-authors include Jakob Ruess, Serge Pelet, John Lygeros, Christoph Zechner, Heinz Koeppl, Matthias Peter, Jutta Horejs‐Hoeck, Reinhard Fässler, Tanja Nicole Hartmann and Richard Greil and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and Nature Immunology.

In The Last Decade

Peter W. Krenn

17 papers receiving 467 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Peter W. Krenn 286 126 58 41 41 18 472
Luciene Borges 403 1.4× 184 1.5× 64 1.1× 45 1.1× 17 0.4× 20 610
Sen Hou 230 0.8× 183 1.5× 38 0.7× 105 2.6× 34 0.8× 23 449
Tomonori Higuchi 250 0.9× 134 1.1× 205 3.5× 64 1.6× 51 1.2× 27 560
Ali Rashidfarrokhi 297 1.0× 205 1.6× 69 1.2× 21 0.5× 28 0.7× 10 583
Upneet K. Sokhi 327 1.1× 157 1.2× 107 1.8× 12 0.3× 33 0.8× 21 572
Fabian Richter 213 0.7× 130 1.0× 129 2.2× 15 0.4× 19 0.5× 23 455
Wolfgang Wienhold 132 0.5× 197 1.6× 59 1.0× 17 0.4× 47 1.1× 10 412
Helen Ferry 165 0.6× 386 3.1× 64 1.1× 49 1.2× 21 0.5× 27 637
Renold J. Capocasale 175 0.6× 161 1.3× 111 1.9× 101 2.5× 68 1.7× 17 432
Jesse E. Jun 245 0.9× 403 3.2× 93 1.6× 29 0.7× 29 0.7× 9 603

Countries citing papers authored by Peter W. Krenn

Since Specialization
Citations

This map shows the geographic impact of Peter W. Krenn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter W. Krenn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter W. Krenn more than expected).

Fields of papers citing papers by Peter W. Krenn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter W. Krenn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter W. Krenn. The network helps show where Peter W. Krenn may publish in the future.

Co-authorship network of co-authors of Peter W. Krenn

This figure shows the co-authorship network connecting the top 25 collaborators of Peter W. Krenn. A scholar is included among the top collaborators of Peter W. Krenn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter W. Krenn. Peter W. Krenn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Blöchl, Constantin, Ancuela Andosch, Peter W. Krenn, et al.. (2025). Inhibition of NLRP3 enhances pro-apoptotic effects of FLT3 inhibition in AML. Cell Communication and Signaling. 23(1). 53–53.
2.
Krenn, Peter W., Gernot Posselt, Christof Regl, et al.. (2024). ADP-heptose attenuates Helicobacter pylori -induced dendritic cell activation. Gut Microbes. 16(1). 2402543–2402543. 6 indexed citations
3.
Unger, Michael S., Christof Regl, Stephan Winkler, et al.. (2023). The Class IIA Histone Deacetylase (HDAC) Inhibitor TMP269 Downregulates Ribosomal Proteins and Has Anti-Proliferative and Pro-Apoptotic Effects on AML Cells. Cancers. 15(4). 1039–1039. 5 indexed citations
4.
Li, Lixia, Peter W. Krenn, Cornelius Miething, et al.. (2023). The Integrin Adaptor Kindlin-3 Is a Gatekeeper for Germinal Center Responses and the Development of Chronic Lymphocytic Leukemia. Blood. 142(Supplement 1). 82–82. 1 indexed citations
5.
Krenn, Peter W. & Fritz Aberger. (2023). Targeting cancer hallmark vulnerabilities in hematologic malignancies by interfering with Hedgehog/GLI signaling. Blood. 142(23). 1945–1959. 6 indexed citations
6.
Wannemacher, Juliane, Simon Christ, Tim Koopmans, et al.. (2022). Neutrophils direct preexisting matrix to initiate repair in damaged tissues. Nature Immunology. 23(4). 518–531. 73 indexed citations
7.
Krenn, Peter W., Eloi Montañez, Mercedes Costell, & Reinhard Fässler. (2022). Integrins, anchors and signal transducers of hematopoietic stem cells during development and in adulthood. Current topics in developmental biology. 149. 203–261. 6 indexed citations
8.
Krenn, Peter W., et al.. (2022). The cytokine network in acute myeloid leukemia. Frontiers in Immunology. 13. 1000996–1000996. 34 indexed citations
9.
Krenn, Peter W., et al.. (2022). Hedgehog/GLI signaling in hematopoietic development and acute myeloid leukemia—From bench to bedside. Frontiers in Cell and Developmental Biology. 10. 944760–944760. 5 indexed citations
10.
Krenn, Peter W., Steffen Koschmieder, & Reinhard Fässler. (2020). Kindlin-3 loss curbs chronic myeloid leukemia in mice by mobilizing leukemic stem cells from protective bone marrow niches. Proceedings of the National Academy of Sciences. 117(39). 24326–24335. 17 indexed citations
11.
Margraf, Andreas, Giulia Germena, Hannes C. A. Drexler, et al.. (2020). The integrin-linked kinase is required for chemokine-triggered high-affinity conformation of the neutrophil β2-integrin LFA-1. Blood. 136(19). 2200–2205. 29 indexed citations
12.
Krenn, Peter W., Sebastian W. Hofbauer, Ursula Denk, et al.. (2016). ILK Induction in Lymphoid Organs by a TNFα–NF-κB–Regulated Pathway Promotes the Development of Chronic Lymphocytic Leukemia. Cancer Research. 76(8). 2186–2196. 12 indexed citations
13.
Catusse, Julie, Manuela Paunovic, Katja Zirlik, et al.. (2016). BCR and chemokine responses upon anti-IgM and anti-IgD stimulation in chronic lymphocytic leukaemia. Annals of Hematology. 95(12). 1979–1988. 12 indexed citations
14.
Merkel, Olaf, Ana‐Iris Schiefer, Nicole Prutsch, et al.. (2015). Oncogenic role of miR‐155 in anaplastic large cell lymphoma lacking the t(2;5) translocation. The Journal of Pathology. 236(4). 445–456. 44 indexed citations
15.
Brachtl, Gabriele, Daniela Asslaber, Peter W. Krenn, et al.. (2015). CXCL12-induced VLA-4 activation is impaired in trisomy 12 chronic lymphocytic leukemia cells: a role for CCL21. Oncotarget. 6(14). 12048–12060. 15 indexed citations
16.
Hofbauer, Sebastian W., Peter W. Krenn, Daniela Asslaber, et al.. (2014). Tiam1/Rac1 signals contribute to the proliferation and chemoresistance, but not motility, of chronic lymphocytic leukemia cells. Blood. 123(14). 2181–2188. 60 indexed citations
17.
Zechner, Christoph, Jakob Ruess, Peter W. Krenn, et al.. (2012). Moment-based inference predicts bimodality in transient gene expression. Proceedings of the National Academy of Sciences. 109(21). 8340–8345. 145 indexed citations
18.
Barnas, C., J. Tauscher, B. Küfferle, et al.. (1997). P.2.069 123I IBZM spect imaging of dopamine-2 receptors in psychotic patients treated with zotepine. European Neuropsychopharmacology. 7. S215–S215. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026